Expression of polypeptide N-acetylgalactosaminyl transferase-3 and its association with clinicopathological factors in thyroid carcinomas

Thyroid

Volumn 23, Issue 12, 2013, Pages 1553-1560

  Mochizuki, Yasuhiro ^a   Ito, Ken Ichi ^a   Izumi, Hiroto ^b   Kohno, Kimitoshi ^b   Amano, Jun ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; N ACETYLGALACTOSAMINYLTRANSFERASE; POLYPEPTIDE;

ADULT; ANAPLASTIC CARCINOMA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL FEATURE; DIFFERENTIATED THYROID CANCER; EPITHELIUM CELL; FEMALE; FOLLICULAR CARCINOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDULLARY CARCINOMA; MULTIMODALITY CANCER THERAPY; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY;

ADULT; CARCINOMA; FEMALE; HUMANS; MALE; MIDDLE AGED; N-ACETYLGALACTOSAMINYLTRANSFERASES; NEOPLASM STAGING; PROGNOSIS; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84890320267     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2012.0613     Document Type: Article

References (44)

1. Sherman SI 2003 Thyroid carcinoma. Lancet 361: 501-511. (Pubitemid 36173719)
2. Voutilainen PE, Multanen M, Haapiainen RK, Leppaniemi AK, Sivula AH 1999 Anaplastic thyroid carcinoma survival. World J Surg 23:975-978; discussion 978-979.
3. Ito K, Hanamura T, Murayama K, Okada T, Watanabe T, Harada M, Ito T, Koyama H, Kanai T, Maeno K, Mochizuki Y, Amano J 2012 Multimodality therapeutic outcomes in anaplastic thyroid carcinoma: improved survival in subgroups of patients with localized primary tumors. Head Neck 34: 230-237.
4. Hakomori S 1989 Aberrant glycosylation in tumors and tumor- associated carbohydrate antigens. Adv Cancer Res 52: 257-331.
5. Nakamori S, Ota DM, Cleary KR, Shirotani K, Irimura T 1994 MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma. Gastroenterology 106: 353-361. (Pubitemid 24041211)
6. Hattrup CL, Gendler SJ 2008 Structure and function of the cell surface (tethered) mucins. Annu Rev Physiol 70: 431-457. (Pubitemid 351738187)
7. Dube DH, Bertozzi CR 2005 Glycans in cancer and inflammation - potential for therapeutics and diagnostics. Nat Rev Drug Discov 4: 477-488. (Pubitemid 40861990)
8. Hollingsworth MA, Swanson BJ 2004 Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 4: 45-60. (Pubitemid 38082153)
9. Ogawa J, Sano A, Koide S, Shohtsu A 1994 Relation between recurrence and expression of proliferating cell nuclear antigen, sialyl LewisX, and sialyl Lewis(a) in lung cancer. J Thorac Cardiovasc Surg 108: 329-336. (Pubitemid 24258672)
10. Rice GE, Bevilacqua MP 1989 An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science 246: 1303-1306. (Pubitemid 20066715)
11. Itzkowitz SH, Bloom EJ, Kokal WA, Modin G, Hakomori S, Kim YS 1990 Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer 66:1960- 1966. (Pubitemid 20385969)
12. Nakamori S, Kameyama M, Imaoka S, Furukawa H, Ishikawa O, Sasaki Y, Kabuto T, Iwanaga T, Matsushita Y, Irimura T 1993 Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res 53: 3632-3637. (Pubitemid 23229648)
13. Niklinski J, Furman M, Laudanski J, Kozlowski M 1992 Prognostic value of pretreatment CEA, SCC-Ag and CA 19- 9 levels in sera of patients with non-small cell lung cancer. Eur J Cancer Prev 1: 401-406.
14. Diez M, Torres A, Maestro ML, Ortega MD, Gomez A, Pollan M, Lopez JA, Picardo A, Hernando F, Balibrea JL 1996 Prediction of survival and recurrence by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable nonsmall- cell lung cancer. Br J Cancer 73: 1248-1254. (Pubitemid 26162341)
15. Ohgami A, Tsuda T, Osaki T, Mitsudomi T, Morimoto Y, Higashi T, Yasumoto K 1999 MUC1 mucin mRNA expression in stage I lung adenocarcinoma and its association with early recurrence. Ann Thorac Surg 67: 810-814. (Pubitemid 29204749)
16. Bresalier RS, Niv Y, Byrd JC, Duh QY, Toribara NW, Rockwell RW, Dahiya R, Kim YS 1991 Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis. J Clin Invest 87: 1037-1045.
17. Bresalier RS 1994 Adhesion molecules and gastrointestinal malignancies. Gastroenterology 106: 1378-1382. (Pubitemid 24129259)
18. Sutherlin ME, Nishimori I, Caffrey T, Bennett EP, HassanH, Mandel U, Mack D, Iwamura T, Clausen H, Hollingsworth MA 1997 Expression of three UDP-N-acetyl-alpha-Dgalactosamine: polypeptide GalNAc N- acetylgalactosaminyltransferases in adenocarcinoma cell lines. Cancer Res 57: 4744-4748. (Pubitemid 27468980)
19. Hagen FK, Van Wuyckhuyse B, Tabak LA 1993 Purification, cloning, and expression of a bovine UDP-GalNAc: polypeptide N-acetyl- galactosaminyltransferase. J Biol Chem 268: 18960-18965. (Pubitemid 23273846)
20. Tarp MA, Clausen H 2008 Mucin-type O-glycosylation and its potential use in drug and vaccine development. Biochim Biophys Acta 1780: 546-563. (Pubitemid 351381249)
21. Yoshimura Y, Nudelman AS, Levery SB, Wandall HH, Bennett EP, Hindsgaul O, Clausen H, Nishimura S 2012 Elucidation of the sugar recognition ability of the lectin domain of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3 by using unnatural glycopeptide substrates. Glycobiology 22: 429-438.
22. Homa FL, Hollander T, Lehman DJ, Thomsen DR, Elhammer AP 1993 Isolation and expression of a cDNA clone encoding a bovine UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase. J Biol Chem 268: 12609-12616. (Pubitemid 23182423)
23. White T, Bennett EP, Takio K, Sorensen T, Bonding N, Clausen H 1995 Purification and cDNA cloning of a human UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetyl galactosaminyltransferase. J Biol Chem 270: 24156-24165.
24. Bennett EP, Hassan H, Clausen H 1996 cDNA cloning and expression of a novel human UDP-N-acetyl-alpha-D-galactosamine. Polypeptide N- acetylgalactosaminyltransferase, GalNAc-t3. J Biol Chem 271: 17006-17012. (Pubitemid 26244245)
25. Onitsuka K, Shibao K, Nakayama Y, Minagawa N, Hirata K, Izumi H, Matsuo K, Nagata N, Kitazato K, Kohno K, Itoh H 2003 Prognostic significance of UDP-N-acetyl-alpha-Dgalactosamine: polypeptide N- acetylgalactosaminyltransferase- 3 (GalNAc-T3) expression in patients with gastric carcinoma. Cancer Sci 94: 32-36. (Pubitemid 36575855)
26. Dosaka-Akita H, Kinoshita I, Yamazaki K, Izumi H, Itoh T, Katoh H, Nishimura M, Matsuo K, Yamada Y, Kohno K 2002 N-acetylgalactosaminyl transferase-3 is a potential new marker for non-small cell lung cancers. Br J Cancer 87: 751-755. (Pubitemid 35189613)
27. Shibao K, Izumi H, Nakayama Y, Ohta R, Nagata N, Nomoto M, Matsuo K, Yamada Y, Kitazato K, Itoh H, Kohno K 2002 Expression of UDP-N-acetyl-alpha-D- galactosaminepolypeptide galNAc N-acetylgalactosaminyl transferase-3 in relation to differentiation and prognosis in patients with colorectal carcinoma. Cancer 94: 1939-1946. (Pubitemid 34270046)
28. Miyahara N, Shoda J, Kawamoto T, Furukawa M, Ueda T, Todoroki T, Tanaka N, Matsuo K, Yamada Y, Kohno K, Irimura T 2004 Expression of UDP-N-acetyl-alpha-Dgalactosamine- polypeptide N-acetylgalactosaminyltransferase isozyme 3 in the subserosal layer correlates with postsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder. Clin Cancer Res 10: 2090-2099. (Pubitemid 38375571)
29. Inoue T, Eguchi T, Oda Y, Nishiyama K, Fujii K, Izumi H, Kohno K, Yamaguchi K, Tanaka M, Tsuneyoshi M 2007 Expression of GalNAc-T3 and its relationships with clinicopathological factors in 61 extrahepatic bile duct carcinomas analyzed using stepwise sections - special reference to its association with lymph node metastases. Mod Pathol 20: 267-276. (Pubitemid 46422168)
30. Yamamoto S, Nakamori S, Tsujie M, Takahashi Y, Nagano H, Dono K, Umeshita K, Sakon M, Tomita Y, Hoshida Y, Aozasa K, Kohno K, Monden M 2004 Expression of uridine diphosphate N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase 3 in adenocarcinoma of the pancreas. Pathobiology 71: 12-18. (Pubitemid 37256022)
31. Ishikawa M, Kitayama J, Kohno K, Nagawa H 2005 The expression pattern of UDP-N-acetyl-alpha-D-galactosaminepolypeptide N-acetyl-galactosaminyl transferase-3 in squamous cell carcinoma of the esophagus. Pathobiology 72: 139-145. (Pubitemid 40674997)
32. Nomoto M, Izumi H, Ise T, Kato K, Takano H, Nagatani G, Shibao K, Ohta R, Imamura T, Kuwano M, Matsuo K, Yamada Y, Itoh H, Kohno K 1999 Structural basis for the regulation of UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase-3 gene expression in adenocarcinoma cells. Cancer Res 59: 6214-6222. (Pubitemid 30035645)
33. Ramirez AT, Gibelli B, Tradati N, Giugliano G, Zurlo V, Grosso E, Chiesa F 2007 Surgical management of thyroid cancer. Expert Rev Anticancer Ther 7: 1203-1214. (Pubitemid 47521017)
34. Are C, Shaha AR 2006 Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches. Ann Surg Oncol 13: 453-464.
35. van de Graaf SA, Pauws E, de Vijlder JJ, Ris-Stalpers CR 1997 The revised 8307 base pair coding sequence of human thyroglobulin transiently expressed in eukaryotic cells. Eur J Endocrinol 136: 508-515. (Pubitemid 27239612)
36. Yang SX, Pollock HG, Rawitch AB 1996 Glycosylation in human thyroglobulin: location of the N-linked oligosaccharide units and comparison with bovine thyroglobulin. Arch Biochem Biophys 327: 61-70. (Pubitemid 26063734)
37. Whitley RJ, Ain KB 2004 Thyroglobulin: a specific serum marker for the management of thyroid carcinoma. Clin Lab Med 24: 29-47. (Pubitemid 38638108)
38. Lin JD 2008 Thyroglobulin and human thyroid cancer. Clin Chim Acta 388: 15-21.
39. Tarutani O, Ui N 1985 Properties of thyroglobulins from normal thyroid and thyroid tumor on a concanavalin Asepharose column. J Biochem 98: 851-857. (Pubitemid 16216431)
40. Shimizu K, Nakamura K, Kobatake S, Satomura S, Maruyama M, Kameko F, Tajiri J, Kato R 2007 The clinical utility of Lens culinaris agglutinin-reactive thyroglobulin ratio in serum for distinguishing benign from malignant conditions of the thyroid. Clin Chim Acta 379: 101-104. (Pubitemid 46366975)
41. Kanai T, Amakawa M, Kato R, Shimizu K, Nakamura K, Ito K, Hama Y, Fujimori M, Amano J 2009 Evaluation of a new method for the diagnosis of alterations of Lens culinaris agglutinin binding of thyroglobulin molecules in thyroid carcinoma. Clin Chem Lab Med 47: 1285-1290.
42. Rosai J 2003 Immunohistochemical markers of thyroid tumors: significance and diagnostic applications. Tumori 89: 517-519. (Pubitemid 37541608)
43. Ordonez NG, El-Naggar AK, Hickey RC, Samaan NA 1991 Anaplastic thyroid carcinoma. Immunocytochemical study of 32 cases. Am J Clin Pathol 96: 15-24.
44. Wiseman SM, Masoudi H, Niblock P, Turbin D, Rajput A, Hay J, Bugis S, Filipenko D, Huntsman D, Gilks B 2007 Anaplastic thyroid carcinoma: expression profile of targets for therapy offers new insights for disease treatment. Ann Surg Oncol 14: 719-729. (Pubitemid 46175318)